Neuropsychiatric Effects of Anabolic Steroids in Male Normal Volunteers

JAMA: The Journal of the American Medical Association

Volumn 269, Issue 21, 1993, Pages 2760-2764

  Su, Tung Ping ^a   Pagliaro, Michael ^b   Schmidt, Peter J ^a   Pickar, David ^a   Wolkowitz, Owen ^a,c   Rubinow, David R ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; BENORTERONE; METHYLTESTOSTERONE; PLACEBO;

ARTICLE; BEHAVIOR DISORDER; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; HUMAN; HUMAN EXPERIMENT; MALE; MOOD; NEUROPSYCHIATRY; NORMAL HUMAN; OLIGURIA; PRIORITY JOURNAL; PRURITUS; SUICIDE;

ADOLESCENT; ADULT; AFFECT; ANABOLIC STEROIDS; BEHAVIOR; COGNITION; DOUBLE-BLIND METHOD; HUMAN; MALE; METHYLTESTOSTERONE; PROSPECTIVE STUDIES; PSYCHOLOGICAL TESTS;

EID: 0027322147     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1993.03500210060032     Document Type: Article

References (36)

1. Physicians’ Desk Reference. 43rd ed. Oradell, NJ: Medical Economics Co Inc; 1989:851-852.
2. Cowart VS. National Institute on Drug Abuse may join in anabolic steroid research. JAMA. 1989; 261:1855-1857.
3. Council on Scientific Affairs, American Medical Association. Drug abuse in athletes: anabolic steroids and human growth hormone. JAMA. 1988;259: 1703-1705.
4. Kashkin KB, Kleber HD. Hooked on hormones? an anabolic steroid addiction hypothesis. JAMA. 1989; 262:3166-3170.
5. Williamson DJ, Young AH. Psychiatric effects of androgenic and anabolic-androgenic steroid abuse in men: a brief review of the literature. J Psychopharmacol. 1992;6:20-26.
6. Annitto WJ, Layman WA. Anabolic steroids and acute schizophrenic episode: case reports. J Clin Psychiatry. 1980;41:143-144.
7. Freinhar JP, Alverez W. Androgen-induced hypomania. J Clin Psychiatry. 1985;46:354-355.
8. Tilzey A, Heptonstall J, Hamblin T. Toxic confusional state and choreiform movements after treatment with anabolic steroids. BMJ. 1981;285:349-350.
9. Barker S. Oxymethalone and aggression. Br J Psychiatry. 1987;151:564.
10. Pope HG Jr, Katz DL. Affective and psychotic symptoms associated with anabolic steroid use. Am J Psychiatry. 1988;145:487-490.
11. Choi PYL, Parrott AC, Cowan D. High-dose anabolic steroids in strength athletes: effects upon hostility and aggression. Hum Psychopharmacol. 1990;5:349-356.
12. Lefavi RG, Reeve TG, Newland MC. Relationship between anabolic steroid use and selected psychological parameters in male bodybuilders. J Sport Behav. 1990;13:157-166.
13. Perry PJ, Yates WR, Andersen KH. Psychiatric symptoms associated with anabolic steroids: a controlled, retrospective study. Ann Clin Psychiatry. 1990;2:11-17.
14. Bahrke MS, Wright JE, O’Connor JS, Strauss RH, Catlin DH. Selected psychological characteristics of anabolic-androgenic steroid users. N Engl J Med. 1990;323:834-835.
15. Brower KJ, Blow FC, Eliopulos GA, Beresford TP. Anabolic androgenic steroids and suicide. Am J Psychiatry. 1989;146:1075.
16. Brower KJ, Blow FC, Beresford TP, Fuelling C. Anabolic-androgenic steroid dependence. J Clin Psychiatry. 1989;50:31-33.
17. Tennant F, Black DL, Voy RO. Anabolic steroid dependence with opioid-type features. N Engl J Med. 1988;319:578.
18. Vogel W, Klaiber EL, Broverman DM. A comparison of the antidepressant effects of a synthetic androgen (mesterolone) and amitriptyline in depressed men. J Clin Psychiatry. 1985;46:6-8.
19. Itil TM, Michael ST, Soldatos C. Androgens as antidepressants. Psychopharmacol Bull. 1979;15: 31-35.
20. Itil TM, Cora R, Akpinar S, Herrmann WM, Patterson CJ. ‘Psychotropic’ action of sex hormones: computerized EEG in establishing the immediate CNS effects of steroid hormones. Curr Ther Res. 1974;16:1147-1167.
21. Beumont PJV, Bancroft JHJ, Beardwood CJ. Behavioural changes after treatment with testosterone: a case report. Psychol Med. 1972;2:70-72.
22. Itil TM, Michael ST, Shapiro DM, Itil KZ. The effects of mesterolone, a male sex hormone, in depressed patients (a double blind controlled study). Methods Find Exp Clin Pharmacol. 1984;6:331-337.
23. Wilson I, Prange A, Lara P. Methyltestosterone with imipramine in men: conversion of depression to paranoid reactions. Am J Psychiatry. 1974; 131:21-24.
24. Spitzer RL, Endicott J. Schedule for Affective Disorders and Schizophrenia—Lifetime Version, New York, NY: New York State Psychiatric Institute, Biometrics Research; 1975.
25. Hyler SE, Rieder RO, Williams JBW, Spitzer RL, Lyons M, Hendler J. A comparison of clinical and self-report diagnoses of DSM-III personality disorders in 552 patients. Compr Psychiatry. 1989; 30:170-178.
26. Hyler SE, Rieder RO. Personality Diagnostic Questionnaire (PDQ)—Revised (PDQ-R). New York, NY: New York State Psychiatric Institute; 1987.
27. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.
28. Spielberger CB, Gorsuch RL, Luschene RE. STAI Manual for the State-Trait Anxiety Inventory. Palo Alto, Calif: Consulting Psychologists Press; 1970.
29. Derogatis LR, Lipman RS, Covi L. The SCL-90: an outpatient psychiatric rating scale. Psychopharmacol Bull. 1973;9:13-28.
30. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep. 1962;10:799-812.
31. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;12:56-62.
32. Folstein MF, Folstein SE, McHugh PR. ‘Mini-Mental State,’ a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
33. Colburn TR, Smith BM, Guarini JJ, Simmons NN. An ambulatory activity monitor with solid state memory. Instrument Soc Am Trans. 1976;15:149-154.
34. Lal S, Vasavan Nair NP, Thavundayil JX, Tawar V, Guyda H, Ayotte C. The effect of methyltestosterone on the growth hormone response to the dopamine receptor agonist, apomorphine. Prog Neuropsychopharmacol Biol Psychiatry. 1991;15:263-268.
35. Hannan CJ Jr, Friedl KE, Zold A, Kettler TM, Plymate SR. Psychological and serum homovanillic acid changes in men administered androgenic steroids. Psychoneuroendocrinology. 1991;16:335-343.
36. Tourtellotte WW, Haerer AF, Heller GL, Somers JE. Post-Lumbar Puncture Headaches. Springfield, Ill: Charles C Thomas Publisher; 1964.